Expensify (EXFY) Competitors $1.92 -0.04 (-2.04%) Closing price 04:00 PM EasternExtended Trading$1.94 +0.02 (+0.78%) As of 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EXFY vs. DAVA, WEAV, DOMO, OSPN, DH, ECX, LZMH, CANG, CCSI, and BLZEShould you be buying Expensify stock or one of its competitors? The main competitors of Expensify include Endava (DAVA), Weave Communications (WEAV), Domo (DOMO), Onespan (OSPN), Definitive Healthcare (DH), ECARX (ECX), LZ Technology (LZMH), Cango (CANG), Consensus Cloud Solutions (CCSI), and Backblaze (BLZE). These companies are all part of the "computer software" industry. Expensify vs. Its Competitors Endava Weave Communications Domo Onespan Definitive Healthcare ECARX LZ Technology Cango Consensus Cloud Solutions Backblaze Expensify (NASDAQ:EXFY) and Endava (NYSE:DAVA) are both small-cap computer software companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations. Do analysts prefer EXFY or DAVA? Expensify currently has a consensus price target of $4.00, indicating a potential upside of 108.33%. Endava has a consensus price target of $20.78, indicating a potential upside of 110.30%. Given Endava's higher possible upside, analysts plainly believe Endava is more favorable than Expensify.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Expensify 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Endava 0 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.30 Which has stronger earnings & valuation, EXFY or DAVA? Endava has higher revenue and earnings than Expensify. Expensify is trading at a lower price-to-earnings ratio than Endava, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExpensify$139.24M1.11-$10.06M-$0.16-12.00Endava$999.23M0.58$27.45M$0.4521.96 Which has more risk and volatility, EXFY or DAVA? Expensify has a beta of 1.72, meaning that its share price is 72% more volatile than the S&P 500. Comparatively, Endava has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500. Does the media prefer EXFY or DAVA? In the previous week, Endava had 13 more articles in the media than Expensify. MarketBeat recorded 16 mentions for Endava and 3 mentions for Expensify. Expensify's average media sentiment score of 0.53 beat Endava's score of 0.17 indicating that Expensify is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Expensify 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Endava 3 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 2 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in EXFY or DAVA? 68.4% of Expensify shares are held by institutional investors. Comparatively, 62.2% of Endava shares are held by institutional investors. 12.3% of Expensify shares are held by company insiders. Comparatively, 18.8% of Endava shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is EXFY or DAVA more profitable? Endava has a net margin of 2.73% compared to Expensify's net margin of -10.72%. Endava's return on equity of 5.56% beat Expensify's return on equity.Company Net Margins Return on Equity Return on Assets Expensify-10.72% -12.02% -8.52% Endava 2.73%5.56%3.62% SummaryEndava beats Expensify on 11 of the 16 factors compared between the two stocks. Get Expensify News Delivered to You Automatically Sign up to receive the latest news and ratings for EXFY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EXFY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EXFY vs. The Competition Export to ExcelMetricExpensifyFinancial Transaction Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$154.66M$32.51B$26.38B$10.15BDividend YieldN/A2.20%2.77%4.60%P/E Ratio-12.0038.8327.1825.92Price / Sales1.1116.27754.6385.33Price / CashN/A17.7527.0359.91Price / Book1.167.267.776.29Net Income-$10.06M$1.11B$199.14M$270.77M7 Day PerformanceN/A3.33%9.73%3.36%1 Month Performance6.67%6.36%20.13%6.41%1 Year Performance-17.95%29.30%68.51%28.24% Expensify Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EXFYExpensify2.4178 of 5 stars$1.92-2.0%$4.00+108.3%-19.3%$154.66M$139.24M-12.00140DAVAEndava4.6955 of 5 stars$10.02-1.6%$20.78+107.4%-69.4%$600.94M$999.23M22.2612,085WEAVWeave Communications3.2862 of 5 stars$7.90+1.9%$15.10+91.1%-22.7%$597.03M$204.31M-19.75890News CoveragePositive NewsDOMODomo3.6223 of 5 stars$15.07+3.1%$17.00+12.8%+132.2%$588.24M$317.04M-7.77920Analyst ForecastOSPNOnespan4.922 of 5 stars$15.60+2.6%$19.67+26.1%+3.6%$582.92M$243.18M10.33790News CoveragePositive NewsDHDefinitive Healthcare1.1742 of 5 stars$4.15+3.8%$4.73+14.1%-2.8%$572.57M$252.20M-1.57970Positive NewsECXECARX2.5871 of 5 stars$1.58+2.6%$3.20+102.5%+0.6%$570.92M$761.90M-4.391,918Positive NewsShort Interest ↓LZMHLZ TechnologyN/A$3.42-6.0%N/AN/A$546MN/A0.0067News CoverageCANGCango2.5164 of 5 stars$5.52+9.4%$8.00+45.1%+188.1%$523.07M$110.21M-1.912,350High Trading VolumeCCSIConsensus Cloud Solutions2.5655 of 5 stars$27.15+1.3%$27.40+0.9%+31.2%$508.77M$350.38M6.54460News CoveragePositive NewsBLZEBackblaze2.3075 of 5 stars$9.14+5.1%$10.07+10.2%+60.3%$491.55M$127.63M-10.27270Positive NewsGap Down Related Companies and Tools Related Companies Endava Competitors Weave Communications Competitors Domo Competitors Onespan Competitors Definitive Healthcare Competitors ECARX Competitors LZ Technology Competitors Cango Competitors Consensus Cloud Solutions Competitors Backblaze Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EXFY) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Expensify, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Expensify With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
